GeneDx Holdings (WGS) EBITDA Margin Growth (1y) (2021 - 2026)
Powered by 
Analysis
GeneDx Holdings (WGS) EBITDA Margin Growth (1y) (2021 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Natera | 53.05 Bn | 51.95 Bn | 486.15 Mn | 1,012.00 |
| 2 | Quest Diagnostics | 27.19 Bn | 26.87 Bn | 1.03 Bn | -78.00 |
| 3 | Labcorp Holdings | 25.93 Bn | 25.81 Bn | 1.11 Bn | 92.00 |
| 4 | Guardant Health | 23.97 Bn | 22.91 Bn | 219.03 Mn | 731.00 |
| 5 | Tempus AI | 13.64 Bn | 12.82 Bn | 274.25 Mn | -21.00 |
| 6 | Caris Life Sciences | 8.47 Bn | 7.68 Bn | 182.38 Mn | 2,013.00 |
| 7 | Sotera Health | 5.35 Bn | 4.99 Bn | 177.96 Mn | 97.00 |
| 8 | BillionToOne | 4.96 Bn | 4.41 Bn | 77.11 Mn | 747.00 |
| 9 | Adaptive Biotechnologies | 4.55 Bn | 4.21 Bn | 51.39 Mn | -1,173.00 |
| 10 | GeneDx Holdings | 3.01 Bn | 2.88 Bn | 78.24 Mn | -2,398.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -2,398.00 |
| Mar 31, 2026 | -5,098.00 |
| Dec 31, 2025 | -2,097.00 |
| Sep 30, 2025 | 734.00 |
| Jun 30, 2025 | 2,373.00 |
| Mar 31, 2025 | 1,666.00 |
| Dec 31, 2024 | 5,387.00 |
| Sep 30, 2024 | 7,049.00 |
| Jun 30, 2024 | 9,098.00 |
| Mar 31, 2024 | 11,805.00 |
| Dec 31, 2023 | 48,489.00 |
| Sep 30, 2023 | 2,850.00 |
| Jun 30, 2023 | 34,370.00 |
| Mar 31, 2023 | 2,563.00 |
| Dec 31, 2022 | -32,925.00 |
| Sep 30, 2022 | 9,531.00 |
| Jun 30, 2022 | -35,302.00 |
| Mar 31, 2022 | 14,075.00 |
| Dec 31, 2021 | -479.00 |
| Sep 30, 2021 | -5,933.00 |